Estimated reading time: 1 minutes
Patients with a common heart arrhythmia called Atrial Fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.
About The Author
Discover more from Life is Pro-Mazing!
Subscribe to get the latest posts sent to your email.